**Core tip:** We performed a prospective study to investigate the reproducibility of *in vivo* endoscopic ultrasound (EUS) - guided needle based confocal endomicroscopy (nCLE) image patterns in an *ex vivo* setting and compare these to surgical histopathology for pancreatic cystic lesions (PCLs). A total of 10 subjects underwent *in vivo* EUS-nCLE and subsequently *ex vivo* CLE of the PCL following surgical resection. Biopsies were obtained from *ex vivo* CLE-imaged areas for comparative histopathology. We found that characteristic *in vivo* nCLE patterns were observed during *ex vivo* pCLE of resected PCLs. Both *in vivo* and *ex vivo* CLE imaging findings correlated with surgical histopathology. These findings support the application of EUS-nCLE in the diagnosis of PCLs.

INTRODUCTION
============

Pancreatic cancer is projected to move from the third to second leading cause of cancer mortality before 2020\[[@B1]\]. In contrast to the steady survival increase for most other cancers, advances in management for pancreatic cancer have been less than modest with the 5-year relative survival rate is currently 8%\[[@B1]\]. The primary reason for the low survival is difficulty in early identification of pancreatic cancer. While pancreatic cystic lesions (PCLs) provide an opportunity for early cancer detection as many have malignant potential. There has been a surge in incidental detection of PCLs due to increasing utilization of cross-sectional imaging, but diagnostic differentiation of these lesions remains challenging\[[@B2],[@B3]\].

Despite judicious utilization of endoscopic ultrasound (EUS), fine needle aspiration (FNA), cyst fluid analysis, and cytology, it is challenging to accurately classify PCLs into non-mucinous \[serous cystadenomas (SCA), pseudocysts\], pre-malignant mucinous \[intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasms (MCN)\], and neoplastic \[cystic-neuroendocrine tumors (NET), pseudopapillary tumor\] PCLs. This is highlighted by a recent study at a large tertiary center involving 851 resected cystic tumors where the associated etiology for one in five cases was benign in nature\[[@B4]\].

Confocal laser endomicroscopy (CLE) offers real-time microscopic imaging of tissue where the system provides tissue-sequences with high resolution (1-3.5 μm) facilitating *in vivo* histopathology. Needle-based CLE (nCLE) is a new technology to evaluate PCLs where the device is pre-loaded in a 19-guage FNA needle for evaluation of the intracystic epithelium. Recent major trials have established reference standards and have all assessed the safety profile and feasibility of diagnostic capabilities of EUS-guided nCLE in patients with PCLs\[[@B5]-[@B8]\]. More over *in vivo* nCLE image patterns for PCLs have been internally and externally validated among independent observers\[[@B7]-[@B10]\].

While *ex vivo* confirmation of *in vivo* CLE findings has been demonstrated in diagnosis of Barrett's esophagus and gastric adenocarcinoma, there are no human studies corroborating CLE findings of PCLs using *ex-vivo* examination and surgical histopathology\[[@B11]-[@B13]\]. We have previously published the technique and individual case reports of IPMN, MCN, SCA, and cystic-NET demonstrating potential feasibility for correlation between *in vivo* and *ex vivo* nCLE imaging with surgical histopathology\[[@B14]-[@B20]\].

The aim of this study was to validate the *in vivo* EUS-nCLE image patterns of specific types of PCLs by reproducing identical images in *ex vivo* pCLE examination and correlation with surgical histopathology.

MATERIALS AND METHODS
=====================

Patient population
------------------

The Institutional Review Board approved this prospective study, which was conducted at The Ohio State University Wexner Medical Center. From June 2015 to December 2016, all consenting subjects who underwent EUS-nCLE with subsequent surgical resection were enrolled in the INDEX study (Comparison of confocal laser endomicroscopic *in vivo* Diagnosis and *ex vivo* examination against surgical histopathology of cystic pancreatic lesions; ClinicalTrials.gov NCT02516488). An informed consent was obtained for both aspects (*in vivo* and *ex vivo*) aspects of the study. Our criteria for using EUS-nCLE included: (1) ≥ 18 years of age; (2) a PCL lesion size of ≥ 20 mm (determined by cross-sectional imaging studies); and (3) evaluation for surgical removal based on recommended international consensus guidelines\[[@B21]\]. Exclusion criteria were: (1) women with known pregnancy at the time of procedure; (2) coagulopathy (INR \> 1.5 and/or platelets \< 50000/mL); and (3) known allergy to fluorescein. *Ex vivo* pCLE of PCLs was performed on representative cases of common types of PCLs.

Data collection
---------------

Demographics, history of present illness, laboratory data, and image findings were collected using a standardized data collection form. Imaging data were compiled with those from EUS to describe: location, number and size of the PCLs, lesion characteristics, evidence of dilation of the main pancreatic duct, and presence of communication with the pancreatic duct. One gastrointestinal pathologist reviewed all surgical histopathology specimens and the biopsies obtained during *ex vivo* CLE examination.

In vivo EUS-nCLE image acquisition
----------------------------------

All EUS examinations were performed at The Ohio State University Medical Center using a linear echoendoscope (Olympus America, Center Valley, PA, United States). All EUS examinations were performed under the direction of an anesthesiologist utilizing intravenous (IV) propofol. Fluorescein (5 mL; 10% fluorescein sodium) was intravenously injected 2 to 3 min prior to CLE imaging. The AQ-Flex nCLE miniprobe (Cellvizio, Mauna Kea Technologies, Paris, France) was then advanced through the locking device into the 19-gauge (g) needle (Flex needle, Boston Scientific, Natick, MA, United States). The preloaded 19-g needle was advanced under EUS-guidance into the PCL. The tip of the nCLE probe was negotiated until it opposed the intracystic epithelium. Intracystic endomicroscopic images (video) were captured with permissible angulation of the 19 g needle using the elevator of the echoendoscope. After image acquisition, the nCLE probe was withdrawn and the PCL was aspirated. Antibiotic (quinolone) prophylaxis was administered *via* IV route on the day of procedure followed by 3 d of oral therapy.

Ex vivo pCLE image acquisition
------------------------------

We have recently published a video manual of the *ex vivo* pCLE imaging technique\[[@B19]\]. Immediately prior to resection of the part of the pancreas with the cystic lesion and under the direction of the surgeon and anesthetist, fluorescein (10%, 5 mL) was intravenously injected before ligation of blood vessels supplying the pancreas. Following resection, the specimen was transported to the pathology-processing laboratory for immediate processing as the pre-ligation IV fluorescein is retained for a maximum of one hour after injection. The pathologist then incised the cyst along the long axis using their standard processing technique. The epithelium of the PCL was then imaged using a Gastroflex ultrahigh definition probe (UHD) probe (Cellvizio, Mauna Kea Technologies, Paris, France) at 3-5 random areas based on the size of the cyst. Site-specific biopsies were then obtained at the pCLE-imaged areas using standard endoscopy biopsy forceps (Radial Jaw 4, Boston Scientific, Natick, MA, United States). The *ex vivo* biopsies were obtained from the PCL sites providing the clearest pCLE image.

Comparison of the CLE probes
----------------------------

The specific characteristics of the CLE probes used for the study are described in Table [1](#T1){ref-type="table"}. The AQ-Flex nCLE probe was used during *in vivo* EUS-guided approach while the Gastroflex-UHD pCLE probe with high-definition image acquisition was used during *ex vivo* post-surgical cyst interrogation. The larger GastroFlex-UHD miniprobe has increased number of fiber optics and provides higher magnification and improved resolution; however, due to its size, the probe cannot be accommodated through the working channel of 19-g EUS needle. This concept of comparing *in vivo* to *ex vivo* imaging is derived from a prior study showing enhanced image acquisition of Gastroflex when compared to CholangioFlex miniprobe (Cellvizio, Mauna Kea Technologies, Paris, France) for assessing indeterminate biliary strictures where individual structures were more easily identified\[[@B22]\]. The Gastroflex-UHD probe has a superior lateral resolution of 1 μm, compared to 3.5 μm for the Cholangioflex probe. The lateral resolutions of the AQ-Flex and Cholangioflex probes are identical\[[@B23]\].

###### 

Comparison of confocal laser endomicroscopy probes and standard microscope

                             **Device**     **Channel size (mm)**   **Field of view (μm)**   **Resolution (μm)**   **Confocal depth (μm)**
  -------------------------- -------------- ----------------------- ------------------------ --------------------- -------------------------
  Gastroflex^TM^ UHD         Probe based    ≥ 2.8                   240                      1.00                  55-65
  AQ-Flex^TM^ 19             Needle based   ≥ 0.91                  325                      3.50                  40-70
  Cholangioflex^TM^          Probe based    ≥ 1.0                   325                      3.50                  40-70
  Standard microscopy × 20   Microscope     NA                      NA                       0.70                  NA
  Standard microscopy × 40   Microscope     NA                      NA                       0.45                  NA

UHD: Ultrahigh definition probe.

Histopathology
--------------

The resected specimen underwent standard histopathologic processing. The biopsies obtained from pCLE imaged specific sites also underwent standard processing under the supervision of a gastroenterologist pathologist.

Statistical analysis
--------------------

A dedicated software (Cellvizio Viewer, version 1.6.1; Mauna Kea Technologies, Paris, France) was used to review all *in vivo* and *ex vivo* CLE videos and images. A diligent frame-by-frame review of the videos was performed multiple times to document the most illustrative image patterns. The various image patterns observed during CLE examination of the PCLs are described in Table [2](#T2){ref-type="table"}. There was no blinded assessment of the pre-and postoperative CLE images.

###### 

Classification, description, and associated cyst type confocal laser endomicroscopy image patterns

  **Variable**         **Explanation of patterns**                                                                                                                                                **Cyst type where pattern is observed**
  -------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------
  Papillae             A papilla is a finger-like projection of variable length consisting of an overlying epithelium and underlying vascular core                                                IPMN
  Epithelial bands     Epithelial bands are either single or multiple layers of epithelium without a papillary configuration. These bands demonstrated layering or a horizon-type configuration   MCN
  Trabecular pattern   Nests of cells separated by blood vessels of fibrous bands                                                                                                                 Cystic-NET
  Fern pattern         A concentrated network of parallel vessels emanating from a central vessel similar to a fern-leaf                                                                          SCA

PCL: Pancreatic cystic lesion; IPMN: Intraductal papillary mucinous neoplasm; MCN: Mucinous cystic neoplasm; Cystic-NET: Cystic neuroendocrine tumor; SCA: Serous cystadenoma.

Comparison of standard microscopy and CLE imaging
-------------------------------------------------

CLE imaging offers an "en-face" view and has resolutions ranging from 1 μm (Gastroflex probe) to 3.5 μm (AQ-Flex probe). In comparison, standard biopsy or surgical resection and histopathology reveals a "transverse view", but offers a much higher resolution than CLE imaging, which increases with magnification (Table [1](#T1){ref-type="table"}).

RESULTS
=======

Study cohort
------------

A total of 10 subjects (mean age 53 ± 12 years \[SD\]; 5 female) underwent EUS-nCLE with surgical resection and subsequent *ex vivo* imaging (Table [3](#T3){ref-type="table"}). The mean size of PCLs was 34.8 ± 14.3 mm with the majority of lesions located in the tail (*n =* 5) when compared to head/uncinate (*n =* 2) or neck/body region (*n =* 3). No adverse events occurred during the surgical resection that impacted the quality of the specimen.

###### 

Pancreatic Cystic Lesion Characteristics: Demographics, clinical features, cyst imaging, fluid characteristics, and final diagnosis

  **Subject**   **Corresponding Figure**   **Gender**   **Age**   **Abdominal symptoms**   **Size (mm)**   **Location**    **MPD communication**   **MPD dilation**   **Cyst CEA** **(ng/dL)**   **Final diagnosis**     **Pathological features**
  ------------- -------------------------- ------------ --------- ------------------------ --------------- --------------- ----------------------- ------------------ -------------------------- ----------------------- ---------------------------
  1             1A-C                       Female       67        Symptomatic              21              Head/uncinate   Yes                     Yes                188                        IPMN                    Gastric subtype
                                                                                                                                                                                                                         High grade dysplasia
  2             1D-F                       Male         71        Incidental               40              Head/uncinate   Yes                     Yes                Very viscous               IPMN                    Intestinal subtype
                                                                                                                                                                                                                         High grade dysplasia
  4             2A-C                       Female       47        Incidental               28              Neck/body       No                      No                 6512                       Mucinous                Low grade
                                                                                                                                                                                                 cystadenoma             
  3             2D-F                       Female       51        Symptomatic              41              Neck/body       No                      Yes                76                         Mucinous                Low grade
                                                                                                                                                                                                 cystadenoma             
  5             2G-I                       Female       45        Symptomatic              24              Neck/body       No                      Yes                2400                       Mucinous                Low to moderate grade
                                                                                                                                                                                                 cystadenoma             
  6             3A-C                       Male         44        Symptomatic              57              Tail            No                      No                 1.5                        Cystic-NET              
  7             3D-F                       Male         30        Incidental               21              Tail            No                      No                 4.7                        Cystic-NET              
  8             4A-C                       Female       59        Incidental               60              Tail            No                      No                 0.5                        Serous cystadenoma      
  9             5A-C                       Male         52        Incidental               31              Tail            No                      No                 Pasty aspirate             Lymphoepithelial cyst   
  10            6A-D                       Male         62        Incidental               25              Tail            No                      No                 2664                       Epidermoid cyst         

MPD: Main pancreatic duct; CEA: Carcinoembryonic antigen; CEA: Carcinoembryonic antigen; Cystic-NET: Cystic neuroendocrine tumor; IPMN: Intraductal papillary mucinous neoplasm

Intraductal papillary mucinous neoplasm
---------------------------------------

Complete "finger-like" papillary projections were seen on *in vivo* EUS-nCLE and *ex vivo* pCLE imaging for both patients with IPMNs (Figure [1](#F1){ref-type="fig"}). The vascular cores (lamina propria) of the papillae were better defined in the *ex vivo* imaging. There was no difference in *in vivo* or *ex vivo* imaging between the different subtypes (gastric *vs* intestinal) of IPMN lesions. The CLE images and histopathology were similar.

![*In vivo* endoscopic ultrasound guided needle based confocal laser endomicroscopy, *ex vivo* confocal laser endomicroscopy, and histopathology of intraductal papillary mucinous neoplasms. Panels A, B and C are from subject 1 (gastric subtype with high grade dysplasia). Panels D, E, and F are from subject 2 (intestinal subtype with high grade dysplasia). Complete "fingerlike" papillae are observed in both *in vivo* and *ex vivo* CLE. The vascular core in *ex vivo* CLE imaging is better defined. Histopathology (panels C, F): 40 × magnification; HE stain.](WJG-23-3338-g001){#F1}

Mucinous cystic neoplasm
------------------------

EUS-nCLE demonstrated horizon-type epithelial bands of variable thickness without papillary conformation (Figure [2](#F2){ref-type="fig"} and Table [3](#T3){ref-type="table"}). *Ex vivo* imaging showed thicker epithelial bands with improved definition. MCN with moderate grade dysplasia (Figure [2](#F2){ref-type="fig"}, panels G to I) revealed a thicker epithelial band. During *in vivo* nCLE, MCNs revealed areas of denuded epithelium as evidenced by lack of visualizing any epithelial bands. Few foci of dark background with bright particles (auto-fluorescent inflammatory cells) were also observed representing areas of chronic inflammation. While the characteristic "ovarian stroma" was detected in histopathology, no corresponding CLE features were observed.

![*In vivo* endoscopic ultrasound guided needle based confocal laser endomicroscopy, *ex vivo* confocal laser endomicroscopy, and histopathology of mucinous cystic neoplasms. Panels A, B, and C are from subject 3 (low grade). Panels D, E, and F are from subject 4 (low grade). Panels G, H, and I are from subject 5 (low to moderate grade). Epithelial bands with incomplete papillary formation are observed in CLE. The *in vivo* CLE demonstrates horizon like bands where *ex vivo* CLE demonstrates better defined epithelial bands. Corresponding histopathology (panel C, × 40 and panel F, × 20) show low grade dysplasia and panel I (× 40) reveals moderate grade dysplasia. CLE: Confocal laser endomicroscopy.](WJG-23-3338-g002){#F2}

Cystic neuroendocrine tumor
---------------------------

*In vivo* and *ex vivo* imaging (Figure [3](#F3){ref-type="fig"} and Table [3](#T3){ref-type="table"}) revealed dark clusters or trabeculae of cells separated by bright vascular spaces. Corroborating this finding, corresponding biopsies from the cystic-NETs revealed characteristic well-differentiated NETs, which were confirmed by immunostaining.

![*In vivo* endoscopic ultrasound guided needle based confocal laser endomicroscopy, *ex vivo* confocal laser endomicroscopy, and histopathology of cystic neuroendocrine tumor. Panels A, B, and C are from subject 6. Panels D, E, and F are from subject 7. Circumscribed clusters of cells in a trabecular growth pattern separated by vascular or fibrous cords are observed on confocal laser endomicroscopy examination. Histopathology (panels C, × 40; panel F, × 20) revealed characteristic uniform tumor cells arranged in cords or trabecular fashion.](WJG-23-3338-g003){#F3}

Serous cystadenoma
------------------

Both EUS-nCLE and *ex vivo* imaging (Figure [4](#F4){ref-type="fig"} and Table [3](#T3){ref-type="table"}) depict a "fern pattern" of vascularity that is best described as a concentrated parallel or interconnected network of vessels emanating from a larger vessel (similar to a fern leaf). However, the vascular pattern observed in CLE imaging is not represented in histopathology. Characteristic histology of SCAs include multiple cystic spaces lined by cuboidal/flat epithelial cells. The pathology image in Figure [4](#F4){ref-type="fig"} (panel C) revealed flattened cystic spaces lined by cuboidal epithelial cells.

![*In vivo* endoscopic ultrasound guided needle based confocal laser endomicroscopy, *ex vivo* confocal laser endomicroscopy, and histopathology of serous cystadenoma. Confocal laser endomicroscopy images, panels A (*in vivo*) and B (*ex vivo*) depict "fern pattern" of vascularity (subject 8). Histopathology (panel C; HE, × 40) reveals cuboidal to flat epithelial cells with clear cytoplasm lining some cystic spaces.](WJG-23-3338-g004){#F4}

Squamous lined cysts (epidermoid and lymphoepithelial cysts)
------------------------------------------------------------

Two distinct benign cysts, epidermoid cyst of intra pancreatic accessory spleen (IPAS) and lymphoepithelial cyst, were included in this study. The epidermoid cyst of IPAS demonstrated cords of cells suggestive of ectopic splenic tissue. Pathology confirmed these findings revealing a thin squamous epithelium and underlying splenic red pulp (Figure [5](#F5){ref-type="fig"} and Table [3](#T3){ref-type="table"}). On the other hand, the lymphoepithelial cyst had clusters of bright particles that correlated to keratinous debris seen on pathologic slides (Figure [6](#F6){ref-type="fig"} and Table [3](#T3){ref-type="table"}). Microscopy demonstrated keratin flakes and the cyst wall was lined by squamous epithelium bordered by abundant lymphoid tissue.

![*In vivo* endoscopic ultrasound guided needle based confocal laser endomicroscopy, *ex vivo* confocal laser endomicroscopy, and histopathology of epidermoid cyst of intra pancreatic accessory spleen. Confocal laser endomicroscopy images, panels A (*in vivo*) and B (*ex vivo*) reveal underlying splenic tissue (panels C, red pulp). Histopathology shows thin epithelial layer (squamous) with underlying ectopic splenic tissue (HE, × 40).](WJG-23-3338-g005){#F5}

![*In vivo* endoscopic ultrasound guided needle based confocal laser endomicroscopy, *ex vivo* confocal laser endomicroscopy, and histopathology of lymphoepithelial cyst. Confocal laser endomicroscopy images, A (*in vivo*) and B (*ex vivo*) reveal clusters of bright particles representing keratin flakes. Macroscopically the lesion was filled with yellowish pasty material which by microscopy (panel C) demonstrated keratin flakes. The cyst was lined by squamous epithelium surrounded by abundant lymphoid tissue (panel D; HE, × 40).](WJG-23-3338-g006){#F6}

DISCUSSION
==========

This study confirms the reproducibility of *in vivo* EUS-nCLE image patterns in *ex vivo* pCLE examination of surgically resected PCLs. The histopathology from CLE imaged site-specific biopsies were comparable to CLE patterns. Some variations in histological views can be explained by higher resolution and the plane of image reproduction. While EUS-nCLE produces *en-face* microscopic imaging of the epithelium of PCLs, tissue histology reveals transverse views. To our knowledge, this is the largest study describing *in vivo* and *ex vivo* CLE findings in definitively diagnosed PCLs. We have correlated for the first time, CLE image patterns with surgical histopathology among common PCLs. These promising findings and growing body of literature lend support to further investigation of EUS-nCLE in the management of PCLs.

The management of PCLs continues to pose challenges. Suboptimal classification and risk stratification of PCLs can lead to inappropriate surgeries or false reassurances. The current guidelines for management of PCLs are not robust since the diagnostic accuracy of current standard of care (cyst fluid CEA, cytology) is inadequate. There is an increasing need for tools to accurately diagnose PCLs. Over the last 5 years, there is an accumulative body of evidence of applying EUS-nCLE or novel cyst fluid molecular makers in diagnosing PCLs\[[@B6]-[@B10],[@B24]\].

Imaging data from three major clinical trials have recognized specific nCLE image patterns for diagnosing PCLs\[[@B5]-[@B8]\]. We have recently validated (internally and externally, inter-and intraobserver) nCLE image patterns of common PCLs\[[@B9],[@B10]\]. We have also published on the technique of *in vivo* and *ex vivo* CLE imaging of PCLs, and individual nCLE *video reports* of IPMNs, MCNs, SCAs, Cystic-NETs, and squamous lined cysts\[[@B15]-[@B18],[@B20]\]. In this study, we performed *ex vivo* CLE examination of resected PCLs from subjects enrolled in a prospective study.

For EUS-nCLE aided diagnosis, IPMNs were diagnosed by the presence of finger-like papillae. Although the nCLE image patterns for MCNs were slightly insufficient, they contained a characteristic either single or multiple (layered) band-like epithelium\[[@B8],[@B9]\]. Thus, the presence of complete papillae or single/multiple band-like epithelium was diagnostic of a mucinous PCL. The diagnosis of IPMNs tends to be easier than that of MCNs since the latter demonstrate relatively flat or horizon-type epithelium which can be patchy with atrophic areas and foci of inflammation\[[@B25],[@B26]\]. We have observed that some MCNs can demonstrate bright inflammatory cells on a dark background suggestive of chronic inflammation similar to pseudocysts\[[@B7],[@B8]\].

A characteristic "superficial vascular network" or "fern pattern" has been observed in SCAs where the specificity approached 100%\[[@B5]-[@B10]\]. Comparable image reproduction in *ex vivo* CLE imaging and corresponding histopathological image supports evidence from current studies. The nCLE imaging of cystic-NETs and comparable *ex vivo* image patterns and correlative histopathology confirm published reports\[[@B8],[@B15]\]. Some rare types of PCLs can be difficult to distinguish by cross sectional imaging and are often evaluated for malignant potential\[[@B27]\]. Thus, awareness of *in vivo* EUS-nCLE image patterns of rare squamous lined PCLs (lymphoepithelial cyst and epidermoid cyst of IPAS) is useful as it may help avoid unnecessary surgical resection.

The small sample size (*n* = 10) is not suitable for statistical analysis and the images observed in this study may not fully characterize all patients with the examined cyst types. As with other novel diagnostic modalities, we anticipate further refinement of technical aspects and additional characterization of nCLE imaging patterns in the future. Although our *ex vivo* nCLE image findings were not externally validated, we have previously performed both internal and external validation of the *in vivo* nCLE image patterns\[[@B9],[@B10]\]. Lastly, since surgical resection of pseudocysts rarely performed, we did not perform *ex vivo* imaging of these lesions within the study period.

In conclusion, the evaluation of PCLs continues to pose a challenge. In uncertain clinical situations, a composite approach including clinical features, imaging characteristics, cyst fluid CEA, cytological examination, and nCLE is necessary. The correlation of histopathology and the reproducibility of *in vivo* and *ex vivo* CLE imaging patterns supports the application of EUS-nCLE as an imaging biomarker in the diagnosis of PCLs. Multicenter prospective studies are needed to confirm whether EUS-nCLE alone or in combination with cyst fluid molecular markers can facilitate desirable outcomes in managing pancreatic cystic lesions.

COMMENTS
========

Background
----------

Endoscopic ultrasound (EUS) and fine needle aspiration (FNA) are standard of care for evaluation of pancreatic cystic lesions (PCLs). Needle-based CLE (nCLE) is a new technology that offers real-time microscopic imaging of tissue facilitating *in vivo* histopathology. The authors have previously published the technique of *in vivo* and *ex vivo* CLE imaging of PCLs. The aim of this study was to validate the *in vivo* EUS-nCLE image patterns of specific types of PCLs by reproducing identical images in *ex vivo* pCLE examination and correlation with surgical histopathology.

Research frontiers
------------------

The current guidelines for management of PCLs are not robust since the diagnostic accuracy of current standard of care is inadequate. There is an increasing need for novel technology to accurately diagnose PCLs. Over the last 5 years, there is an accumulative body of evidence of applying EUS-nCLE in diagnosing PCLs.

Applications
------------

This study confirms the reproducibility of *in vivo* EUS-nCLE image patterns in *ex vivo* pCLE examination of surgically resected PCLs. The histopathology from CLE imaged site-specific biopsies were comparable to CLE patterns. These promising findings lend support to the application of EUS-nCLE in the management of PCLs.

Terminology
-----------

Confocal laser endomicroscopy: A novel endoscopic technology that offers real-time microscopic imaging of tissue where the system provides tissue-sequences with high resolution (1-3.5 μm) facilitating *in vivo* histopathology.

Peer-review
-----------

This new endoscopic technique which is based on confocal microscopy seems very interesting. It allows a pathological diagnosis by acquisition of images that are pathognomonic of the various pancreatic cystic lesions examinated by the authors.
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